The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.
about
Guideline of Chronic Urticaria BeyondChronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapyA review of recent journal highlightsMultiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivityLeukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean populationIs there a role for antileukotrienes in urticaria?Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic TargetsLeukotriene receptor antagonists for chronic urticaria: a systematic review.Management of difficult urticariaAutologous serum therapy in chronic urticaria: a promising complement to antihistamines.The employment of leukotriene antagonists in cutaneous diseases belonging to allergological fieldSystematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments.Severe chronic urticaria treated with oral mini-pulse steroid therapyNew strategies in the treatment and prevention of allergic diseases.Therapeutic potential of macrolide immunosuppressants in dermatology.An update of the leukotriene modulators for the treatment of asthma.Urticaria and angioedema. Controlling acute episodes, coping with chronic cases.EAACI/GA2LEN/EDF guideline: management of urticaria.Emerging drugs for chronic urticaria.Chronic idiopathic urticaria with functional autoantibodies: 12 years on.Montelukast treatment of urticaria.Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.Chronic urticaria: Indian context-challenges and treatment options.Chronic urticaria: assessment of current treatment.Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review.Chronic urticaria: a comparison of management guidelines.Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.Treatment of refractory chronic urticaria: current and future therapeutic options.Update and insights into treatment options for chronic spontaneous urticaria.Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria.Chronic urticaria: new management options.Urticaria Guidelines: Consensus and Controversies in the European and American Guidelines.Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.Current and future therapies for treating chronic spontaneous urticaria.BSACI guideline for the management of chronic urticaria and angioedema.BSACI guidelines for the management of chronic urticaria and angio-oedema.Cyclosporine in chronic idiopathic urticaria with positive autologous serum skin test.Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.Olopatadine in chronic idiopathic urticaria.Patch testing in chronic urticaria.
P2860
Q26743369-574B434C-7515-4302-8528-2376306BABD0Q26777088-1C23C238-6B67-46D6-9DAB-AA33B4C13AA4Q28168449-62AF06EB-DB95-45C2-8424-BFECEC0D9CDFQ28168891-C5AB407E-4E53-4A39-906E-B566B0ED5EBCQ28193999-08DBD87A-BF6F-4AAB-9C00-37EBED25B998Q28217673-E51ABA72-C912-4454-806C-50DD5BFB441AQ28276574-FCF33B76-E34D-434C-B789-A40B9E24C1E2Q33593785-A1A33ED8-8F31-443B-A47E-4831F711EBF5Q33607673-F3D5EC01-4486-41AF-9FA0-EB33A1C1D978Q33919379-46721858-4F68-4FE7-9DA2-E91ACFD0AE63Q34141112-7E3AD25B-940A-45B9-B569-BAB8A183084AQ34454209-9B790B75-EB3B-44CA-8006-CBB0C04B8DFAQ34635886-F20176EF-5A49-467F-9EA1-5247068B8EA4Q35680646-EF63C4FC-B948-4C5E-AEC2-607426CD4AEDQ35680649-260CBA16-121B-4694-96E5-DD79CE532867Q35814442-064E11A9-41BF-4178-93A7-6ED806A95EF8Q36158280-77C79F38-A134-4335-99EF-9811EDF173C8Q36377285-F482B2F2-A3E7-4348-BB94-35DFE99A3458Q36458408-C610BCA5-D4D8-428C-A52D-65A93CA50A4EQ36458515-10B0ADE2-9BAA-432E-84D1-D1DF0CB07D8AQ36466897-C7E37AE2-EE6B-46B7-99C5-B17915DB0267Q36834774-E27ECC97-05BA-481C-A9CC-67D1BC6C92A9Q37239677-4A73765D-9D36-41C2-82EB-F5ED64B15602Q37754628-FE98F065-45E8-446D-957C-CF06673BECE0Q37857698-E13CC23B-624A-4FA1-8055-DD316DB18590Q37950484-3CC9E13F-CB89-41FE-91F8-D6EAF89141B3Q38016756-CFB1220D-FA3A-4D2B-9BDA-8B1AC3304003Q38148494-2BF3B026-0C0F-45AE-AF32-7B7D1B2564A5Q38188032-F1EF02F4-E0B4-4F81-9EA6-5717C5046449Q38217720-5F26B411-8C61-46D8-A419-743C2ACF15A5Q38266463-CCA5273D-59AB-4FDE-8D8B-D52FF3EF9F20Q38542586-29A635AD-A32E-44CF-A8C0-3BE46F6AAB24Q38682862-D45834B8-2A09-42EB-95B1-8A1EFCAD33FDQ38751342-8FF55836-1C4E-4E4B-BA1D-3793BE5A8390Q39035835-52B06A23-DEF0-46E5-8863-CE6A51850E28Q40220185-CA21BBB3-140E-40CE-B2C1-5D60E43E02F8Q42586005-B079533F-0DAB-4023-815E-C5F3A877EE9DQ42736757-10A572BA-CC96-4340-A9DF-98DF1F4A6818Q42751621-7813C7AC-5EEA-4CFB-9030-CAF185451751Q42936382-6C84A209-17CC-4620-9832-8F8FE42EDB3D
P2860
The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The leukotriene receptor antag ...... led, crossover clinical study.
@ast
The leukotriene receptor antag ...... led, crossover clinical study.
@en
The leukotriene receptor antag ...... led, crossover clinical study.
@nl
type
label
The leukotriene receptor antag ...... led, crossover clinical study.
@ast
The leukotriene receptor antag ...... led, crossover clinical study.
@en
The leukotriene receptor antag ...... led, crossover clinical study.
@nl
prefLabel
The leukotriene receptor antag ...... led, crossover clinical study.
@ast
The leukotriene receptor antag ...... led, crossover clinical study.
@en
The leukotriene receptor antag ...... led, crossover clinical study.
@nl
P356
P1476
The leukotriene receptor antag ...... led, crossover clinical study.
@en
P2093
Zülal Erbagci
P304
P356
10.1067/MAI.2002.126676
P407
P577
2002-09-01T00:00:00Z